Biogen-Eisai go for another biomarker approval in Alzheimer’s with lecanemab—and snag priority review

Biogen-Eisai go for another biomarker approval in Alzheimer’s with lecanemab—and snag priority review

https://ift.tt/31eRatO

aarmstrong

via FierceBiotech https://ift.tt/Pi7lFbr

July 6, 2022 at 01:34AM